# Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

> **NCT00769613** · PHASE1 · UNKNOWN · sponsor: **Milton S. Hershey Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** cytomegalovirus IE-1-specific cytotoxic T lymphocytes
- **BIOLOGICAL:** cytomegalovirus pp65-specific cytotoxic T lymphocytes
- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **GENETIC:** polymerase chain reaction
- **OTHER:** flow cytometry
- **OTHER:** immunological diagnostic method
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00769613
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2014-08
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769613, "Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00769613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*